MDGL Operating Cash Flow (Statement)

Madrigal Pharmaceuticals Inc · Operating Cash Flow (Statement)

MDGL logo

MDGL Operating Cash Flow (Statement)

Latest reported-$197.72M
MDGL Cash from Operations (-$23.61M → -$197.72M)
High-resolution chart · PNG

MDGL operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-189,553,000
-455,572,000
-324,230,000
-224,857,000
-183,917,000
-157,561,000
-41,624,000
-25,507,000
-22,317,000
-17,607,620
-71,444,000
-78,925,000
-77,411,000
-54,135,000
-47,300,000
-38,199,000
-26,810,000
-37,939,000
27,222,000
-52,985,000
-61,882,000
-33,795,000
-23,612,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.